BRAF‐V600 mutational status affects recurrence patterns of melanoma brain metastasis-Reference-Cited by-同舟云学术

BRAF‐V600 mutational status affects recurrence patterns of melanoma brain metastasis

Published:2017-04-26 Issue:12 Volume:140 Page:2716-2727
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Maxwell Russell¹,Garzon‐Muvdi Tomas¹,Lipson Evan J.²,Sharfman William H.²,Bettegowda Chetan¹,Redmond Kristin J.³,Kleinberg Lawrence R.³,Ye Xiaobu¹,Lim Michael¹

Affiliation:

1. Department of NeurosurgeryJohns Hopkins Medical InstitutesBaltimore MD

2. Department of OncologyJohns Hopkins Medical InstitutesBaltimore MD

3. Department of Radiation Oncology and Molecular Radiation SciencesJohns Hopkins Medical InstitutesBaltimore MD

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.30241

Reference50 articles.

1. Melanoma in situ

2. Epidemiology of Brain Metastases

3. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma

4. Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

5. Prognostic factors for survival in melanoma patients with brain metastases

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma Brain Metastasis;Hematology/Oncology Clinics of North America;2024-10

2. Prevention of Brain Metastases: A New Frontier;Cancers;2024-06-04

3. High‐risk histopathologic features in local advanced conjunctival melanoma;Acta Ophthalmologica;2024-02-29

4. The Effect of Non-Overlapping Somatic Mutations in BRAF, NRAS, NF1, or CKIT on the Incidence and Outcome of Brain Metastases during Immune Checkpoint Inhibitor Therapy of Metastatic Melanoma;Cancers;2024-01-30

5. Prognostic Value of Baseline 18F-FDG PET/CT to Predict Brain Metastasis Development in Melanoma Patients;Cancers;2023-12-26